Dr. Philip A. Thompson is an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Thompson received his Bachelor of Medicine and Bachelor of Surgery (MB, BS) in Hematology from the University of Melbourne, Australia. He is the recipient of several honors and awards, including Research Fellow of the Year, ASH abstract achievement award, and Celgene’s Future Leaders in Hematology award. Dr. Thompson has authored and co-authored more than 50 peer-reviewed original research articles, invited articles, editorials and abstracts. Dr. Thompson has received research support from Pharmacyclics, Abbvie, Amgen and Acerta Pharma. He is an advisory board member for Pharmacyclics.